CERo Therapeutics Shares To Continue To Trade Under Ticker CERO On OTC Markets

Author: Benzinga Newsdesk | November 03, 2025 08:03am

CERo Therapeutics Holdings, Inc. (OTC:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company developing novel T cell therapeutics that incorporate phagocytic mechanisms, announces its shares continue to be listed on the public markets under the ticker symbol CERO. Effective as of market open on Friday, October 31, 2025, the Company is listed under the OTC PINK with no action needed on the part of investors. In the meantime, CERo is actively evaluating options for up-list, including, but not limited to another OTC market or another major exchange to optimize liquidity and investor accessibility.

Posted In: CERO